Association between estrogen receptor α gene polymorphisms and early restenosis after eversion carotid endarterectomy and carotid stenting

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 186-192

  Hirschberg, Kristóf ^a   Gombos, Tímea ^b   Dósa, Edit ^a   Somorjai, Attila ^a   Szilágyi, Ágnes ^b   Szabó, Gábor ^c   Füst, George ^b   Entz, László ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Carotid artery stenting; Carotid endarterectomy; Estrogen receptor alpha; Gene polymorphism; Restenosis

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; INTERNAL CAROTID ARTERY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTENOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEX DIFFERENCE; STENT;

AGED; AGED, 80 AND OVER; CAROTID STENOSIS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; ENDARTERECTOMY, CAROTID; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECURRENCE; STENTS;

EID: 67651154674     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.027     Document Type: Article

References (30)

1. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340 (1999) 1801-1811
2. Pare G., Krust A., Karas R.H., et al. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 90 (2002) 1087-1092
3. Bakir S., Mori T., Durand J., Chen Y.F., Thompson J.A., and Oparil S. Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. Circulation 101 (2000) 2342-2344
4. Brouchet L., Krust A., Dupont S., Chambon P., Bayard F., and Arnal J.F. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation 103 (2001) 423-428
5. Kolodgie F.D., Jacob A., Wilson P.S., et al. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol 148 (1996) 969-976
6. Bhalla R.C., Toth K.F., Bhatty R.A., Thompson L.P., and Sharma R.V. Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells. Am J Physiol 272 (1997) H1996-2003
7. Parker M.G., Arbuckle N., Dauvois S., Danielian P., and White R. Structure and function of the estrogen receptor. Ann NY Acad Sci 684 (1993) 119-126
8. Karas R.H., Patterson B.L., and Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89 (1994) 1943-1950
9. Ferrero V., Ribichini F., Matullo G., et al. Estrogen receptor-alpha polymorphisms and angiographic outcome after coronary artery stenting. Arterioscler Thromb Vasc Biol 23 (2003) 2223-2228
10. Molvarec A., Ver A., Fekete A., et al. Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia. Hypertens Res 30 (2007) 205-211
11. Peter I., Shearman A.M., Zucker D.R., et al. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens 23 (2005) 2193-2200
12. Schuit S.C., Oei H.H., Witteman J.C., et al. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA 291 (2004) 2969-2977
13. Shearman A.M., Cooper J.A., Kotwinski P.J., et al. Estrogen receptor alpha gene variation and the risk of stroke. Stroke 36 (2005) 2281-2282
14. Shearman A.M., Cupples L.A., Demissie S., et al. Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 290 (2003) 2263-2270
15. Ricotta J.J., O'Brien M.S., and DeWeese J.A. Natural history of recurrent and residual stenosis after carotid endarterectomy: implications for postoperative surveillance and surgical management. Surgery 112 (1992) 656-661 [discussion 662-653]
16. Hunter G.C., and Edgar J. Poth Memorial/W.L. Gore and Associates, Inc. Lectureship. The clinical and pathological spectrum of recurrent carotid stenosis. Am J Surg 174 (1997) 583-588
17. Trisal V., Paulson T., Hans S.S., and Mittal V. Carotid artery restenosis: an ongoing disease process. Am Surg 68 (2002) 275-279 [discussion 279-280]
18. Szeplaki G., Hirschberg K., Gombos T., et al. Early complement activation follows eversion carotid endarterectomy and correlates with the time of clamping of the carotid artery. Mol Immunol 45 (2008) 3289-3294
19. Szabo A., Laki J., Madsen H.O., et al. Early rise in serum VEGF and PDGF levels predisposes patients with a normal MBL2 genotype to restenosis after eversion endarterectomy. Stroke 38 (2007) 2247-2253
20. Dosa E., Szabo A., Prohaszka Z., et al. Changes in the plasma concentration of soluble thrombomodulin in patients with severe carotid artery stenosis after eversion endarterectomy. Inflamm Res 54 (2005) 289-294
21. Biller J., Feinberg W.M., Castaldo J.E., et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 97 (1998) 501-509
22. Entz L., Jaranyi S., and Nemes A. Eversion endarterectomy in surgery of the internal carotid artery. Cardiovasc Surg 4 (1996) 190-194
23. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 577-617
24. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
25. Yadav J.S., Wholey M.H., Kuntz R.E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 (2004) 1493-1501
26. Malek L.A., Malek A.K., Leszczynski J., et al. Carotid clamping time as a risk factor for early restenosis after carotid endarterectomy. Eur J Vasc Endovasc Surg 30 (2005) 143-146
27. Herrington D.M., Howard T.D., Brosnihan K.B., et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105 (2002) 1879-1882
28. Schuit S.C., de Jong F.H., Stolk L., et al. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol 153 (2005) 327-334
29. Alevizaki M., Saltiki K., Cimponeriu A., et al. Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor alpha polymorphic variants. Eur J Endocrinol 156 (2007) 489-496
30. Rokach A., Pollak A., Rosen L., et al. Estrogen receptor alpha gene polymorphisms are associated with the angiographic extent of coronary artery disease. J Clin Endocrinol Metab 90 (2005) 6556-6560